Frequency Therapeutics is a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Our lead product candidate, FX-322, is designed to regenerate auditory hair cells to restore hearing for the most common form of hearing loss.
Location: United States, Massachusetts, Lexington
Employees: 51-200
Total raised: $136M
Founded date: 2015
Investors 4
| Date | Name | Website |
| - | Old Silver... | oldsilverv... |
| - | Proioxis V... | proioxis.v... |
| - | Rivas Capi... | rivascap.c... |
| - | Perceptive... | perceptive... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 24.07.2019 | Series C | $62M | - |
| 08.01.2019 | Series B | $42M | - |
| 11.04.2017 | Series A | $32M | - |
Mentions in press and media 21
| Date | Title | Description | Source |
| 15.04.2022 | Cure for hearing loss as tech company develops breakthrough ... | TechCure for hearing loss as tech company develops breakthrough deafness treatment An American biot... | dailystar.... |
| 09.09.2019 | Frequency Therapeutics registers $100m IPO | Frequency Therapeutics has registered an initial public offering of common stock worth $100 million.... | massdevice... |
| 24.07.2019 | Frequency Therapeutics Closes $62M Series C Financing | Frequency Therapeutics, a Woburn, Mass.-based clinical-stage biotechnology company focused on harnes... | finsmes.co... |
| 24.07.2019 | Frequency Therapeutics snags $62M | Frequency Therapeutics, a developer of small-molecule drugs targeting degenerative diseases, has com... | pitchbook.... |
| 23.07.2019 | Frequency Therapeutics raises another $62 million | Less than a week after Frequency Therapeutics said it had cut a licensing deal with a big Japanese d... | statnews.c... |
| 23.07.2019 | Frequency Therapeutics Completes $62 Million Series C Financ... | WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, a clinical-stage biotechnology company focus... | citybizlis... |
| 08.01.2019 | Term Sheet — Tuesday, January 8 | THE STUDENT DEBT BUBBLE Good morning, Term Sheet readers. Paid Content Securing the enterprise wit... | fortune.co... |
| 08.01.2019 | Frequency Therapeutics secures $42m from Taiwania Capital, A... | Premium US-based Frequency Therapeutics, a clinical-stage biotechnology company creating small mole... | dealstreet... |
| 07.01.2019 | Daily funding roundup - January 7th, 2019 | Synapse Technology raised $6M; Vengo raised $7M; FloWater raised $15M; 10x Genomics raised $35M Syn... | vator.tv/n... |
| 07.01.2019 | Frequency Therapeutics Completes $42M Series B Financing | Frequency Therapeutics, a Woburn, Mass.-based clinical-stage biotechnology company creating a new cl... | finsmes.co... |
Show more